ClinicalTrials.gg
Drug

Axitinib clinical trials

Also written Inlyta and AG-013736.

studies test it
139
open now
18
in phase 3
12
first study started
2002

How each study uses Axitinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Axitinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Jan 2012 · INLYTA · NDA 202324 (FDA, Drugs@FDA)
European Union
3 Sept 2012 · Inlyta · EMEA/H/C/002406 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Axitinib
89
Axitinib (AG-013736)
11
AG-013736 (axitinib)
8
OTX-TKI
4
Axitinib Oral Tablet
2

Brand

Inlyta
38

Development codes

AG-013736
37

Studies by the year they started

139 studies that test it; most in 2011 (13)

Studies that test Axitinib, by start year
YearStudies
20021
20032
20043
20053
20063
20074
20086
20099
20106
201113
201212
20132
20147
20154
20169
20176
20185
20196
20206
20215
20226
20234
20247
20255
20265

By phase

A phase 1/2 study counts in both.

Phase 1
37
Phase 2
94
Phase 3
12
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 45 · Other 94

Pfizer (36) · Ocular Therapeutix, Inc. (5) · M.D. Anderson Cancer Center (5) · National Cancer Institute (NCI) (4) · H. Lee Moffitt Cancer Center and Research Institute (3) · Memorial Sloan Kettering Cancer Center (3) · Chinese University of Hong Kong (3) · The Netherlands Cancer Institute (3)

Often tested with

Tested in the same studies.

Avelumab (13) · Pembrolizumab (11) · Nivolumab (6) · Toripalimab (6) · Crizotinib (6) · Palbociclib (5) · Sunitinib (5) · Erlotinib (5)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 9, 1 in phase 3

Studies that test Axitinib, phase 3 first.

Studies

Open first, then newest update. How each study uses Axitinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 139

See all 139 studies that test Axitinib →

Given beside what is tested · 40 — Axitinib is usual care or a partner of the new treatment

Showing 20 of 40.

As the comparator · 6 — what is tested is compared with Axitinib

Codes

What other systems call Axitinib · ClinicalTrials.gg INT006807

  • MeSH (NLM) D000077784AxitinibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) C9LVQ0YUXGAXITINIBConfirmed FDA, NLM, Wikidata
  • RxNorm 1242999Confirmed FDA, Wikidata
  • Wikidata Q4830631axitinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C38718AxitinibOne source FDA
  • DrugBank DB06626One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.